DK0913394T3 - Fremgangsmåde til fremstilling af formylimidazoler - Google Patents

Fremgangsmåde til fremstilling af formylimidazoler

Info

Publication number
DK0913394T3
DK0913394T3 DK98120019T DK98120019T DK0913394T3 DK 0913394 T3 DK0913394 T3 DK 0913394T3 DK 98120019 T DK98120019 T DK 98120019T DK 98120019 T DK98120019 T DK 98120019T DK 0913394 T3 DK0913394 T3 DK 0913394T3
Authority
DK
Denmark
Prior art keywords
halo
formyl
preparation
ch2oh
peroxide
Prior art date
Application number
DK98120019T
Other languages
English (en)
Inventor
Josef Dr Heveling
Alain Wellig
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of DK0913394T3 publication Critical patent/DK0913394T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56Platinum group metals
    • B01J23/62Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • B01J23/622Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead
    • B01J23/628Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead with lead
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56Platinum group metals
    • B01J23/64Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/644Arsenic, antimony or bismuth
    • B01J23/6447Bismuth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98120019T 1997-10-29 1998-10-22 Fremgangsmåde til fremstilling af formylimidazoler DK0913394T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH250497 1997-10-29

Publications (1)

Publication Number Publication Date
DK0913394T3 true DK0913394T3 (da) 2006-05-08

Family

ID=4235293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98120019T DK0913394T3 (da) 1997-10-29 1998-10-22 Fremgangsmåde til fremstilling af formylimidazoler

Country Status (17)

Country Link
US (1) US5917051A (da)
EP (1) EP0913394B1 (da)
JP (1) JP4423684B2 (da)
KR (1) KR100587187B1 (da)
CN (1) CN1120158C (da)
AT (1) ATE313533T1 (da)
CA (1) CA2251401C (da)
CZ (1) CZ291600B6 (da)
DE (1) DE59813294D1 (da)
DK (1) DK0913394T3 (da)
ES (1) ES2255726T3 (da)
HU (1) HU221057B1 (da)
NO (1) NO309980B1 (da)
PL (1) PL197849B1 (da)
PT (1) PT913394E (da)
SK (1) SK282651B6 (da)
TW (1) TW466235B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100567183B1 (ko) * 1997-11-14 2006-06-13 론자 아게 포르밀이미다졸의제조방법
ES2296348T3 (es) * 1997-11-14 2008-04-16 Lonza Ag Procedimiento de produccion de formilimidazoles.
US20010014743A1 (en) 1997-11-14 2001-08-16 Lonza Ag Procedure for producing formylimidazoles
BR9911172A (pt) * 1998-06-15 2001-03-13 Lonza Ag Procedimento para produção de formil imidazóis
JP2000053651A (ja) * 1998-06-18 2000-02-22 Lonza Ag ホルミルイミダゾ―ル類の製造方法
EP0965590A1 (de) * 1998-06-18 1999-12-22 Lonza A.G. Verfahren zur Herstellung von Formylimidazolen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9110532D0 (en) * 1991-05-15 1991-07-03 Smithkline Beecham Corp Chemical compounds
US5336779A (en) * 1992-10-08 1994-08-09 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method of producing formylimidazoles

Also Published As

Publication number Publication date
NO309980B1 (no) 2001-04-30
PL197849B1 (pl) 2008-05-30
ES2255726T3 (es) 2006-07-01
HUP9802495A2 (hu) 1999-07-28
KR19990037077A (ko) 1999-05-25
HUP9802495A3 (en) 2000-04-28
SK145798A3 (en) 1999-05-07
CN1220990A (zh) 1999-06-30
CA2251401C (en) 2007-09-25
TW466235B (en) 2001-12-01
DE59813294D1 (de) 2006-01-26
JP4423684B2 (ja) 2010-03-03
EP0913394A1 (de) 1999-05-06
HU221057B1 (hu) 2002-07-29
HU9802495D0 (en) 1999-01-28
US5917051A (en) 1999-06-29
EP0913394B1 (de) 2005-12-21
NO985013D0 (no) 1998-10-28
PT913394E (pt) 2006-05-31
NO985013L (no) 1999-04-30
CZ291600B6 (cs) 2003-04-16
CN1120158C (zh) 2003-09-03
SK282651B6 (sk) 2002-11-06
JPH11209348A (ja) 1999-08-03
KR100587187B1 (ko) 2006-10-24
ATE313533T1 (de) 2006-01-15
PL329422A1 (en) 1999-05-10
CZ339598A3 (cs) 1999-05-12
CA2251401A1 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
NO973167D0 (no) Bestemte 1,4,5-trisubstituerte imidazole-forbindelser anvendelige som cytokin
ES2136887T3 (es) Derivados antifungicos de sordaridina.
DK0913394T3 (da) Fremgangsmåde til fremstilling af formylimidazoler
ES2185459A1 (es) Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
DE69906243D1 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
ATE160357T1 (de) Neues antibiotikum, deoxymulündocandin, verfahren zu seiner produktion und verwendung als medikament
DK0916659T3 (da) Fremgangsmåde til fremstilling af formylimidazoler
DK0924195T3 (da) Fremgangsmåde til fremstilling af aminocyanacetamid
ES2139824T3 (es) Uso de 1,4-dihidropiridinas con puente 1,2 como moduladores selectivos de canales de potasio.
DE69101790D1 (de) Verfahren zur Herstellung von Vitamin A Aldehyd.
ATE35982T1 (de) Azetidinderivate.
DK61191A (da) Fremgangsmaade til fremstilling af 1alfa-silyloxy-4alfa-hydroxy-3beta-(3alfa-hydroxy-4-phenoxy-buten-1-yl)-cyclopent-2alfa-yl-alkynderivater
DK0818464T3 (da) Methylsulfomycin I, fremgangsmåde til dets fremstilling og dets anvendelse
ES2054814T3 (es) Proceso quimico.
DE60102035D1 (de) Kuppler und lichtempfindliches photographisches Silberhalogenid-Farbmaterial
DK162188D0 (da) Fremgangsmaade til fremstilling af pentandionderivater
ATE188470T1 (de) Chinolondisulfide als zwischenverbindungen
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
DK504788D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser